KWM
BDRX

Kingsview Wealth Management’s Biodexa Pharmaceuticals BDRX Stock Holding History

Kingsview Wealth Management’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed -$6.49K – 909
2023
Q1 		$6.49K Buy
+1
New +$6.49K ﹤0.01% 880